This company listing is no longer active
AfterNext HealthTech Acquisition Resultados de beneficios anteriores
Pasado controles de criterios 1/6
AfterNext HealthTech Acquisition's earnings have been declining at an average annual rate of -76.8%, while the Capital Markets industry saw earnings growing at 14.5% annually.
Información clave
-76.8%
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de la industria Capital Markets | 10.3% |
| Tasa de crecimiento de los ingresos | n/a |
| Rentabilidad financiera | n/a |
| Margen neto | n/a |
| Última actualización de beneficios | 30 Jun 2023 |
Actualizaciones de resultados anteriores recientes
No hay actualizaciones
Recent updates
No hay actualizaciones
Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero AfterNext HealthTech Acquisition. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 23 | 0 | 4 | 1 | 0 |
| 31 Mar 23 | 0 | 5 | 1 | 0 |
| 31 Dec 22 | 0 | 10 | 1 | 0 |
| 30 Sep 22 | 0 | 17 | 2 | 0 |
Ingresos de calidad: AFTR has high quality earnings.
Margen de beneficios creciente: Insufficient data to determine if AFTR's profit margins have improved over the past year.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Unable to establish if AFTR's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Acelerando crecimiento: Unable to compare AFTR's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Beneficios vs. Industria: AFTR had negative earnings growth (-76.8%) over the past year, making it difficult to compare to the Capital Markets industry average (4.2%).
Rentabilidad financiera
Alta ROE: AFTR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.